Subscribe to Specialty Providers

Specialty Providers

Infusion provider enters Houston market

 - 
01/19/2011

CHICAGO - Home infusion provider CarePoint Partners acquired ivA Lifetec, it was announced Monday.

The acquisition allows the Cincinnati-based CarePoint to expand its presence in Texas.

Twitter: 'Wild West' of CPAP

 - 
01/13/2011

YARMOUTH, Maine - Twitter and other social networking sites can provide a useful forum for health information, but users should take it all with a grain of salt, say CPAP providers.

CPAP provider tweets for sleep

 - 
01/12/2011

RICHMOND, Va. - TheCPAPPeople.com wants CPAP users to know that good therapy is much more than getting a good night's sleep, and the provider is taking to Twitter to spread the word.

ASP: Budesonide reverses decline

 - 
12/22/2010

BALTIMORE - For the third straight quarter, neb-med providers are talking about budesonide, thanks to the drug's ongoing rollercoaster reimbursement.

OIG: Handful of brands account for half of the market

 - 
12/21/2010

There's dozens of different types of diabetes testing supplies, but a select few dominate the market, says a new study by the Office of Inspector General (OIG).

Move over CPAP, there's a new therapy in town

 - 
12/21/2010

Medicare's decision in November to pay for oral appliances to treat sleep apnea barely registered a blip on CPAP providers' radar.

System practically guaranteed outcome

 - 
12/21/2010

The design of Medicare's competitive bidding program all but guaranteed that the majority of mail order diabetes contracts would go to suppliers with very small market share in the product category, says economist Peter Cramton.

UroMed rolls with it

 - 
12/21/2010

UroMed had a busy November. The catheter provider launched a new website, kicked off a TV advertising campaign, expanded its sales territory and, oh yeah, sponsored a local spina bifida event.

Briefs: Mail order provider scores perfect '10'

 - 
12/21/2010

For the 10th straight quarter, Liberator Medical enjoyed "record net revenues," the company reported Nov. 19. Net revenues for the fiscal fourth quarter ending Sept. 30 were $11.49 million, up from $7.856 million for the same quarter in 2009. Net revenues for the year were $40.92 million, up from $25.82 million in 2009.

Diabetes draft yanked

 - 
12/16/2010

BALTIMORE - Looks like CMS will leave the diabetes benefit alone after all.

The Jurisdiction B DME MAC announced Dec. 14 that the DME MACS have rescinded a proposed change to the glucose monitors local coverage determination (LCD).

Pages